Litcius/Paper detail

LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683

C. Le Péchoux, N. Pourel, Fabrice Barlési, Corinne Faivre‐Finn, D. Lerouge, Gérard Zalcman, D. Antoni, B. Lamezec, Ursula Nestle, P. Boisselier, F. Thillays, A. Paumier, Éric Dansin, Karine Peignaux, J. Madelaine, Éric Pichon, Anne Larrouy, Oliver Riesterer, A. Lavolé, A. Bardet

2020Annals of Oncology93 citationsDOIOpen Access PDF

Topics & Concepts

MedicineLung cancerPort (circuit theory)Clinical endpointRadiation therapyAdenocarcinomaRandomized controlled trialSurgeryCancerInternal medicineEngineeringElectrical engineeringLung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingLung Cancer Treatments and Mutations
LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683 | Litcius